{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:07:28Z","timestamp":1791212848287,"version":"4.1.0"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":343,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a range of physical and psychological symptoms, including shortness of breath, chest discomfort, fatigue, fluid congestion, trouble with sleeping, and depression. These symptoms reduce patients' capacity for daily social and physical activity. Usual endpoints of large-scale trials in chronic HF have mostly been defined to evaluate treatments regarding hospitalizations and mortality, but more recently, patients' priorities and needs expressed with QoL are gaining more awareness and are being more extensively evaluated. This scientific statement aims at discussing the importance of QoL in HF, summarizing the most largely adopted questionnaires in HF care, and providing an overview on their application in trials and the potential for their transition to clinical practice. Finally, by discussing the reasons limiting their application in daily clinical routine and the strategies that may promote their implementation, this statement aims at fostering the systematic integration of the patient's standpoint in HF care.<\/jats:p>","DOI":"10.1002\/ejhf.3440","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T06:24:17Z","timestamp":1741760657000},"page":"1159-1173","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Quality of Life in Heart Failure. The Heart of the Matter. A Scientific Statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology"],"prefix":"10.1093","volume":"27","author":[{"given":"Maurizio","family":"Volterrani","sequence":"first","affiliation":[{"name":"IRCCS San Raffaele Roma , Rome ,","place":["Italy"]},{"name":"San Raffaele Open University in Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geza","family":"Halasz","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera San Camillo-Forlanini , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatis","family":"Adamopoulos","sequence":"additional","affiliation":[{"name":"Onassion Hospital , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giuseppe","family":"Agostoni","sequence":"additional","affiliation":[{"name":"Centro Cardiologico Monzino, IRCCS , Milan ,","place":["Italy"]},{"name":"Department of Clinical Sciences and Community Health, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Baylor Scott and White Research Institute , Dallas, Texas ,","place":["USA"]},{"name":"Department of Medicine, University of Mississippi , Jackson, Mississippi ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[{"name":"Heart Research Institute , Sydney, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cohen-Solal","sequence":"additional","affiliation":[{"name":"Universite Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[{"name":"Berlin Insititute of Health Center for Regenerative Therapies, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]},{"name":"Center for Stroke Research Berlin and German Centre for Cardiovascular Research (DZHK), partner site Berlin , Berlin ,","place":["Germany"]},{"name":"Deutsches Herzzentrum der Charit\u00e9, Department of Cardiology (Campus Virchow), Charit\u00e9 Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Jankowska","sequence":"additional","affiliation":[{"name":"University of Wroclaw , Wroclaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore , Singapore ,","place":["Singapore"]},{"name":"Duke-National University of Singapore , Singapore ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterini","family":"Lambrinou","sequence":"additional","affiliation":[{"name":"Cyprus University of Technology , Limassol ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Division of Cardiology, Department of Medicine, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Heart and Vascular Theme, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[{"name":"San Raffaele Cassino Hospital , Cassino ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia , Brescia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Paolillo","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perrone Filardi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Rakisheva","sequence":"additional","affiliation":[{"name":"Cardiology Department, Scientific Institute of Cardiology and Internal Medicine , Almaty ,","place":["Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[{"name":"University Faculty of Medicine, University of Belgrade , Belgrade ,","place":["Serbia"]},{"name":"Serbian Academy of Arts and Sciences , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Gabriele","family":"Tocchetti","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences (DISMET), Center for Basic and Clinical Immunology Research (CISI), Interdepartmental Center for Clinical and Translational Research (CIRCET), Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piepoli","sequence":"additional","affiliation":[{"name":"Clinical Cardiology, IRCCS Policlinico San Donato , Milan ,","place":["Italy"]},{"name":"Department of Biomedical Science for Health, University of Milan , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2026080801404482900_ejhf3440-bib-0001","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1053-2498(01)00298-4","article-title":"Preferences for quality of life or survival expressed by patients with heart failure","volume":"20","author":"Lewis","year":"2001","journal-title":"J Heart Lung Transpl"},{"key":"2026080801404482900_ejhf3440-bib-0002","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jacc.2019.01.072","article-title":"Exercise intolerance in patients with heart failure","volume":"73","author":"Del Buono","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11886-021-01588-y","article-title":"Improving quality of life in heart failure","volume":"23","author":"Freedland","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"2026080801404482900_ejhf3440-bib-0004","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurjhf\/hfr170","article-title":"Ten-year prognosis of heart failure in the community: Follow-up data from the echocardiographic heart of England screening (ECHOES) study","volume":"14","author":"Taylor","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/CIRCOUTCOMES.110.957571","article-title":"Population impact of heart failure and the most common forms of cancer: A study of 1 162 309 hospital cases in Sweden (1988 to 2004)","volume":"3","author":"Stewart","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080801404482900_ejhf3440-bib-0006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.hrtlng.2008.04.002","article-title":"Quality of life in patients with heart failure: Ask the patients","volume":"38","author":"Heo","year":"2009","journal-title":"Heart Lung"},{"key":"2026080801404482900_ejhf3440-bib-0007","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurjhf\/hft071","article-title":"Preferences of heart failure patients in daily clinical practice: Quality of life or longevity?","volume":"15","author":"Kraai","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0008","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1093\/eurheartj\/ehad514","article-title":"Placing patient-reported outcomes at the centre of cardiovascular clinical practice: Implications for quality of care and management","volume":"44","author":"Moons","year":"2023","journal-title":"Eur Heart J"},{"key":"2026080801404482900_ejhf3440-bib-0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1745-0179-1-19","article-title":"Heart failure and health related quality of life","volume":"1","author":"Coelho","year":"2005","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"2026080801404482900_ejhf3440-bib-0010","first-page":"11","volume-title":"Quality of life and pharmacoeconomics in clinical trials","author":"Chipper","year":"1996"},{"key":"2026080801404482900_ejhf3440-bib-0011","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City cardiomyopathy questionnaire: A new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12955-016-0425-7","article-title":"The Minnesota living with heart failure questionnaire: Comparison of different factor structures","volume":"14","author":"Bilbao","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"2026080801404482900_ejhf3440-bib-0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14017430701422454","article-title":"The validation of a new quality of life questionnaire for patients with congestive heart failure\u2013an extension of the cardiac health profile","volume":"41","author":"Mannheimer","year":"2007","journal-title":"Scand Cardiovasc J"},{"key":"2026080801404482900_ejhf3440-bib-0014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12872-023-03197-9","article-title":"Chronic heart failure health-related quality of life questionnaire (CHFQOLQ-20): Development and psychometric properties","volume":"23","author":"Khajavi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2026080801404482900_ejhf3440-bib-0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.JCN.0000317439.82704.e8","article-title":"Development and validation of a patient-centered health-related quality-of-life measure: The chronic heart failure assessment tool","volume":"23","author":"Dunderdale","year":"2008","journal-title":"J Cardiovasc Nurs"},{"key":"2026080801404482900_ejhf3440-bib-0016","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/heart.83.6.634","article-title":"The left ventricular dysfunction questionnaire (LVD-36): Reliability, validity, and responsiveness","volume":"83","author":"O'Leary","year":"2000","journal-title":"Heart"},{"key":"2026080801404482900_ejhf3440-bib-0017","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ejheart.2004.06.006","article-title":"Quality-of-life measurement in chronic heart failure: Do we take account of the patient perspective?","volume":"7","author":"Dunderdale","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0018","first-page":"155","article-title":"EuroQol-5D (EQ-5D): An instrument for measuring quality of life","volume":"78","author":"Balestroni","year":"2012","journal-title":"Monaldi Arch Chest Dis"},{"key":"2026080801404482900_ejhf3440-bib-0019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2026080801404482900_ejhf3440-bib-0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/JCN.0000000000000779","article-title":"The efficacy of psychological interventions on health-related quality of life for patients with heart failure and depression: A systematic review","volume":"37","author":"Helal","year":"2022","journal-title":"J Cardiovasc Nurs"},{"key":"2026080801404482900_ejhf3440-bib-0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchf.2015.10.015","article-title":"Utility of patientreported outcome instruments in heart failure","volume":"4","author":"Kelkar","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0022","volume-title":"Guidance for Industry, Tool Developers, and Food and Drug Administration Staff\u2014Qualification of medical device development tools","author":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health"},{"key":"2026080801404482900_ejhf3440-bib-0023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCOUTCOMES.115.001958","article-title":"Development and validation of a short version of the Kansas City cardiomyopathy questionnaire","volume":"8","author":"Spertus","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080801404482900_ejhf3440-bib-0024","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: A comparison of methods","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"key":"2026080801404482900_ejhf3440-bib-0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardfail.2016.12.002","article-title":"Comparison between the Kansas City cardiomyopathy questionnaire and New York heart association in assessing functional capacity and clinical outcomes","volume":"23","author":"Hawwa","year":"2017","journal-title":"J Card Fail"},{"key":"2026080801404482900_ejhf3440-bib-0026","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: hF-ACTION randomized controlled trial","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0027","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00008483-200207000-00010","article-title":"Relationship between the Minnesota living with heart failure questionnaire and key ventilatory expired gas measures during exercise testing in patients with heart failure","volume":"22","author":"Arena","year":"2002","journal-title":"J Cardiopulm Rehabil"},{"key":"2026080801404482900_ejhf3440-bib-0028","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/eurjhf\/hfq156","article-title":"Improved quality of life in Norwegian heart failure patients after follow-up in outpatient heart failure clinics: Results from the Norwegian heart failure registry","volume":"12","author":"Hole","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0029","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cardfail.2009.05.003","article-title":"Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure","volume":"15","author":"Moser","year":"2009","journal-title":"J Card Fail"},{"key":"2026080801404482900_ejhf3440-bib-0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jchf.2018.02.006","article-title":"Comparing measures to assess health-related quality of life in heart failure with preserved ejection fraction","volume":"6","author":"Napier","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0031","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.amjcard.2018.11.037","article-title":"Comparison of the Kansas City cardiomyopathy questionnaire and Minnesota living with heart failure questionnaire in predicting heart failure outcomes","volume":"123","author":"Yee","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0032","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamacardio.2021.0372","article-title":"Comparison of New York heart association class and patient-reported outcomes for heart failure with reduced ejection fraction","volume":"6","author":"Greene","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02602348","article-title":"Development and testing of a new measure of health status for clinical trials in heart failure","volume":"4","author":"Guyatt","year":"1989","journal-title":"J Gen Intern Med"},{"key":"2026080801404482900_ejhf3440-bib-0034","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1467-9450.1987.tb00758.x","article-title":"Self-assessment of quality of life in severe heart failure: An instrument for clinical use","volume":"28","author":"Wiklund","year":"1987","journal-title":"Scand J Psychol"},{"key":"2026080801404482900_ejhf3440-bib-0035","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"2026080801404482900_ejhf3440-bib-0036","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0037","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000355169","article-title":"Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with \u03b2-blockers: Results of a multicentric observational APULIA study","volume":"92","author":"Riccioni","year":"2013","journal-title":"Pharmacology"},{"key":"2026080801404482900_ejhf3440-bib-0038","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/eurheartj\/ehr343","article-title":"Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: Results from the SHIFT study","volume":"32","author":"Ekman","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080801404482900_ejhf3440-bib-0039","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: The PARALLAX randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.119.044138","article-title":"Effects of dapaglifl on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: Results from the DAPA-HF trial","volume":"141","author":"Kosiborod","year":"2020","journal-title":"Circulation"},{"key":"2026080801404482900_ejhf3440-bib-0041","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehaa1007","article-title":"Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: The EMPEROR-reduced trial","volume":"42","author":"Butler","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080801404482900_ejhf3440-bib-0042","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/eurheartj\/ehaa943","article-title":"Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes","volume":"42","author":"Abraham","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080801404482900_ejhf3440-bib-0043","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.122.059725","article-title":"Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: Results from the EMPULSE trial","volume":"146","author":"Kosiborod","year":"2022","journal-title":"Circulation"},{"key":"2026080801404482900_ejhf3440-bib-0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0045","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0046","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0047","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0048","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin\u2013 Neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0049","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0050","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: A multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"2026080801404482900_ejhf3440-bib-0051","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.119.042929","article-title":"Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction: The DEFINE-HF trial","volume":"140","author":"Nassif","year":"2019","journal-title":"Circulation"},{"key":"2026080801404482900_ejhf3440-bib-0052","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.121.057812","article-title":"Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: The EMPEROR-preserved trial","volume":"145","author":"Butler","year":"2022","journal-title":"Circulation"},{"key":"2026080801404482900_ejhf3440-bib-0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.114.001937","article-title":"Impact of spironolactone on longitudinal changes in health-related quality of life in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"9","author":"Lewis","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0054","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0055","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: The INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0056","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/jama.2020.16641","article-title":"Effect of praliciguat on peak rate of oxygen consumption in patients with heart failure with preserved ejection fraction: The CAPACITY HFpEF randomized clinical trial","volume":"324","author":"Udelson","year":"2020","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0057","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: The VITALITY-HFpEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0058","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/ehf2.13416","article-title":"Changes in quality of life, depression, general anxiety, and heart-focused anxiety after defibrillator implantation","volume":"8","author":"Kindermann","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0059","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0060","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0061","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","article-title":"Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial","volume":"289","author":"Young","year":"2003","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0062","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0063","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1388-9842(01)00176-3","article-title":"The CARE-HF study (CArdiac REsynchronisation in heart failure study): Rationale, design and end-points","volume":"3","author":"Cleland","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0064","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart failure with reduced ejection fraction","volume":"76","author":"Zile","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0066","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/ejhf.2360","article-title":"Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: A systematic review and meta-analysis","volume":"23","author":"Lauder","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0067","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0068","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0069","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2009.03.055","article-title":"Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device","volume":"54","author":"Pagani","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0070","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0071","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ejhf.1838","article-title":"Improving exercise capacity and quality of life using non-invasive heart failure treatments: Evidence from clinical trials","volume":"23","author":"Haehling","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0072","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ejhf.2076","article-title":"OUTSTEP-HF: Randomised controlled trial comparing short-term effects of sacubitril\/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction","volume":"23","author":"Piepoli","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0073","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/ejhf.2355","article-title":"A randomized clinical trial on the short-term effects of 12-week sacubitril\/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: Results from the ACTIVITY-HF study","volume":"23","author":"Halle","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0074","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11886-021-01511-5","article-title":"Patient-reported outcomes in patients with cardiomyopathy","volume":"23","author":"Garcia","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"2026080801404482900_ejhf3440-bib-0075","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jchf.2019.05.015","article-title":"Health-related quality of life in heart failure with preserved ejection fraction","volume":"7","author":"Chandra","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0076","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.121.056824","article-title":"Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial","volume":"144","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"2026080801404482900_ejhf3440-bib-0077","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11897-018-0382-z","article-title":"The evolving role of cardiorespiratory fitness and exercise in prevention and management of heart failure","volume":"15","author":"Omar","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"2026080801404482900_ejhf3440-bib-0078","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026080801404482900_ejhf3440-bib-0079","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2019.02.010","article-title":"Health status after transcatheter mitral-valve repair in heart failure and secondary mitral regurgitation","volume":"73","author":"Arnold","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.106.629261","article-title":"Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York heart association class IV heart failure","volume":"115","author":"Lindenfeld","year":"2007","journal-title":"Circulation"},{"key":"2026080801404482900_ejhf3440-bib-0081","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006512","article-title":"Safety, performance, and efficacy of cardiac contractility modulation delivered by the 2-lead optimizer smart system: The FIX-HF-5C2 study","volume":"13","author":"Wiegn","year":"2020","journal-title":"Circ Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0082","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/ehf2.13126","article-title":"Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function","volume":"7","author":"Tsch\u00f6pe","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0083","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): A randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"2026080801404482900_ejhf3440-bib-0084","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jcin.2020.09.050","article-title":"COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing MitraClip implantation","volume":"14","author":"Adamo","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080801404482900_ejhf3440-bib-0085","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.healun.2020.09.005","article-title":"MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the international MitraBridge registry","volume":"39","author":"Godino","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2026080801404482900_ejhf3440-bib-0086","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-fl left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0087","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jacc.2009.12.052","article-title":"Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients","volume":"55","author":"Rogers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0088","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ehf2.13282","article-title":"Health-related quality of life in left ventricular assist device-supported patients","volume":"8","author":"Itzhaki Ben Zadok","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0089","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2018.12.072","article-title":"Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure","volume":"73","author":"Taylor","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2020.26812","article-title":"Effect of high-intensity interval training, moderate continuous training, or guideline-based physical activity advice on peak oxygen consumption in patients with heart failure with preserved ejection fraction: A randomized clinical trial","volume":"325","author":"Mueller","year":"2021","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0091","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman","year":"2021","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0092","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2016.11.023","article-title":"The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure\u2014A meta-analysis","volume":"227","author":"Giuliano","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026080801404482900_ejhf3440-bib-0093","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ehf2.12227","article-title":"Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction: Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction","volume":"5","author":"Bobenko","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0094","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: A randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"2026080801404482900_ejhf3440-bib-0095","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults","volume":"364","author":"Villareal","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080801404482900_ejhf3440-bib-0096","first-page":"1","article-title":"Exercise-based cardiac rehabilitation for chronic heart failure: The EXTRAMATCH II individual participant data meta-analysis","volume":"23","author":"Taylor","year":"2019","journal-title":"Health Technol Assess"},{"key":"2026080801404482900_ejhf3440-bib-0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2011.09.006","article-title":"Effect of a medication-taking behavior feedback theory\u2013based intervention on outcomes in patients with heart failure","volume":"18","author":"Wu","year":"2012","journal-title":"J Card Fail"},{"key":"2026080801404482900_ejhf3440-bib-0098","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cardfail.2016.06.422","article-title":"What are effective program characteristics of self-management interventions in patients with heart failure? An individual patient data meta-analysis","volume":"22","author":"Jonkman","year":"2016","journal-title":"J Card Fail"},{"key":"2026080801404482900_ejhf3440-bib-0099","volume-title":"Database of abstracts of reviews of effects (DARE): Quality-assessed reviews [Internet]","year":"2014"},{"key":"2026080801404482900_ejhf3440-bib-0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10741-021-10110-z","article-title":"Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: A systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Ghizzardi","year":"2022","journal-title":"Heart Fail Rev"},{"key":"2026080801404482900_ejhf3440-bib-0101","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.hlc.2020.04.019","article-title":"Supportive care interventions to promote health-related quality of life in patients living with heart failure: A systematic review and meta-analysis","volume":"29","author":"Kyriakou","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2026080801404482900_ejhf3440-bib-0102","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/ehf2.12733","article-title":"Motivational interviewing to improve self-care in heart failure patients (MOTIVATE-HF): A randomized controlled trial","volume":"7","author":"Vellone","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026080801404482900_ejhf3440-bib-0103","article-title":"Pattern and predictors of unmet supportive care needs in cancer patients","volume":"9","author":"Okediji","year":"2017","journal-title":"Cureus"},{"key":"2026080801404482900_ejhf3440-bib-0104","doi-asserted-by":"crossref","first-page":"853","DOI":"10.31083\/j.rcm2203091","article-title":"A qualitative metasynthesis of patients with heart failure perceived needs","volume":"22","author":"Kyriakou","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"2026080801404482900_ejhf3440-bib-0105","doi-asserted-by":"crossref","DOI":"10.2196\/39391","article-title":"Designing a future eHealth service for posthospitalization self-management support in long-term illness: Qualitative interview study","volume":"10","author":"Wathne","year":"2023","journal-title":"JMIR Hum Factors"},{"key":"2026080801404482900_ejhf3440-bib-0106","doi-asserted-by":"crossref","DOI":"10.2196\/32946","article-title":"Posthospitalization follow-up of patients with heart failure using eHealth solutions: Restricted systematic review","volume":"24","author":"Morken","year":"2022","journal-title":"J Med Internet Res"},{"key":"2026080801404482900_ejhf3440-bib-0107","volume-title":"Treatment for heart failure: Endpoints for drug development. Guid Ind","author":"FDA","year":"2019"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/7\/1159\/66814515\/eurjhf_27_7_1159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/27\/7\/1159\/66814515\/eurjhf_27_7_1159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:41:02Z","timestamp":1786167662000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/27\/7\/1159\/8468345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":107,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.3440","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"2024-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}